Administration of the immunosuppressive drug cyclosporine after syngeneic o
r autologous bone marrow transplantation elicits a T-lymphocyte-dependent a
utoimmune syndrome similar to graft-versus-host disease (GVHD). The onset o
f this autoaggression syndrome,termed syngeneic GVHD, is associated with th
e development of a highly restricted repertoire of CD8(+) autoreactive T ce
lls that recognize a peptide from the invariant chain, termed CLIP, present
ed by major histocompatibility complex (MHC) class II molecules. Clonal ana
lysis reveals 2 distinct subsets of autoreactive T cells defined by their a
ctivation requirement for either the N-terminal or the C-terminal flanking
regions of CLIP and by their cytokine profile. The studies here reveal that
the autoreactive T-cell clones requiring the N-terminal flanking region of
CLIP produce type 1 cytokines (interferon [IFN]-gamma, interleukin [IL]-2,
and tumor necrosis factor-alpha). In contrast, the autoreactive T-cell clo
nes that require the C-terminal flanking region of CLIP produce type 2 cyto
kines (IL-4, IL-10, transforming growth factor-beta). As assessed in a loca
l graft-versus-host reaction assay, the N-terminal flanking-restricted clon
es mediate changes consistent with acute GVHD, whereas the clones responsiv
e to the C-terminal flanking region do not. Moreover, the autoreactive T-ce
ll clones restricted by the C-terminal flanking region of CLIP ameliorate t
he pathogenic potential of the cells responsive to the N-terminal flanking
region of CLIP. The mechanism accounting for this regulatory affect appears
to be the downregulation of mRNA message for type 1 cytokines (IFN-gamma a
nd IL-2). The C-terminal-restricted autoreactive T-cell clones, however, co
uld manifest disease with dermal changes similar to those seen in chronic s
yngeneic GVHD, provided that IFN-gamma was present. Consistent with these o
bservations was the demonstration that type 1 cytokines are preferentially
detected during the acute phase of syngeneic GVHD, whereas type 2 cytokines
dominate during the chronic phase. The results suggest that acute and chro
nic syngeneic GVHD is mediated by distinct autoreactive T cells, which are
separated by their fine specificity for the CLIP-MHC class II complex and b
y their cytokine profiles.